Recipient of federal assistance · GLEN ROCK, NJ
RESPIRERX PHARMACEUTICALS INC.
RESPIRERX PHARMACEUTICALS INC. received $1.5M in federal grants and other assistance in FY2026, on 2 actions, 0% vs FY2025. It has no federal contracts in the loaded years. Since FY2025: $3M. Its largest awarding agency was National Institutes of Health ($1.5M).
- Assistance · FY2026
- $1.5M
- New awards
- 0
- Actions
- 2
- Since FY2025
- $3M
- UEI
- HWS8C3MQDTH7
- Location
- GLEN ROCK, NJ
Businesses
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
Assistance by fiscal year
- 1.5MFY2025
- 1.5MFY2026
By type
- Grants$1.5M100%
Top programs · Awarding agencies
Obligations in FY2026.
Top programs
- 93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders$1.5M100%
Awarding agencies
- National Institutes of Health$1.5M100%Department of Health and Human Services
Largest awards
- 93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Sep 23, 2025 – Sep 14, 2026· R44NS143576
Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2025–FY2026.